Payer

The ECRI Institute's annual report from its Device Evaluation Program reflects enduring ramifications of the pandemic and cautions healthcare leaders about maintaining connectivity.

Also: Truepill launches a COVID-19 test coverage platform for insurers, and 23andMe extends its partnership with GSK.

Glooko CEO Russ Johannesson predicts that the growth in digital health funding will continue this year, and that the push toward interoperability will be critical for the space.

Areas of opportunity include data analytics for research, enhancing EHR capabilities and using AI algorithms to support patient care and operational efficiency.

Also: Medicare Advantage insurer Zing Health partners with Papa. Verily and biopharma-company Sosei Heptares announce a research collaboration. Pharma-focused accelerator PharmStars’ next cohort will focus on neurological diseases.

More payers launched virtual-first plans, insurtechs went public, and the digital mental health space brought in plenty of funding dollars this year.

It's a seismic acquisition, one that was first floated more than 13 years ago. Now that it's finally happening (pending regulatory approval), observers assess the deal and offer thoughts on what's next.

"There’s no need to wait until October 6. Anyone ready to share more than the USCDI v1 is welcome and encouraged to do so as permitted under applicable law."

As 2021 draws to a close, MobiHealthNews asked executives and other leaders in the digital health space what they expect from the industry next year.

The new digital strategies are allowing the provider to change care delivery because the technology is no longer siloed.